Kelley Shannon T sold 1,077 shares of MADRIGAL PHARMACEUTICALS, INC. at $400.00 for −$431k on Nov 6, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
General Counsel
General Counsel
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$430,800Shares × reported price
Shares traded
1,077Common Stock
Price per share
$400.00Reported price. Read footnotes for ranges.
% of reported position traded
9.39%This security and ownership context
Holdings after
10,397Direct
Trade date
Nov 6, 2026Sell
Filed
Nov 6, 2026, 4:36 PM ET0-day reporting delay
Accession
0001628280-26-071744Code S · Transaction 394965
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 11,474 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MDGL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MDGL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13%1w ago 0%1d ago 0%
Returns since7d −0.8%30d90d180d1y

Footnotes in full

F1: This sale was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2026.